DFM ---ADX ---
1hDubai Crackdown: Over 35,000 E-scooters and Bikes Impounded for Safety ViolationsUAE
1hDubai Airports Supporting SpiceJet Amid Financial ChallengesUAE
2hDubai’s Last-Mile Revolution: The Future of Autonomous PodsUAE
3hDubai Police Shifts to Luxury Settings for Child Victim InterviewsUAE
4hThe Rising Strategic Importance of Precious Metals in Modern IndustryUAE
4hAI-Driven Mapping Enhances Dubai Police Emergency ResponseUAE
5hCould a Tiny Implant Revolutionize Rectal Cancer Treatment? Abu Dhabi Clinical Trial BeginsUAE
5hSheikha Bodour Unveils Global 'Young Voices' Initiative for Aspiring WritersUAE
5hUAE President Welcomes Global Leaders for Upcoming UN Water ConferenceUAE
5hPutin Thanks UAE for Mediating Peace TalksUAE
5hAbu Dhabi Court Reduces Sentences for Hotel Brawl DefendantsUAE
5hBeyond Traditional Cloud Seeding: How the UAE is Using Tech to Create RainUAE
5hUAE Forecast: Cloudy Skies and Light Showers Expected Across Coastal RegionsUAE
5hRevolutionizing Food Safety: How AI and Sewage Surveillance are Changing the GameUAE
5hDXB Sees Steady Recovery as Passenger Traffic Hits 50 MillionBusinessUAE
17hKerala Expat Strikes Gold with Big Ticket WinUAE
1dSharjah’s Al Dhaid City reaches New Milestone with Opening of Entrance BridgeUAE
1dSharjah International Book Fair 2026 Sees Record-Breaking Growth and Global AttendanceUAE
1dSmall Steps, Big Impact: UAE Minister Highlights Simple ParentingUAE
1dAbu Dhabi Expands Green Spaces with 12 New ParksUAE
1dExpanding Cricket’s Reach: The Power of Women’s ParticipationUAE
1dUAE’s Job Market Shows Resilience and A Massive Surge in AI HiringUAE
1dRAK Talent Award Expands to Boost Innovation with Dh1.75 Million in PrizesUAE
1dBoosting Transport Collaboration Between Dubai and Abu DhabiUAE
1dDubai’s High-Tech Shift: AI to Revolutionize Food Safety InspectionsUAE

Could a Tiny Implant Revolutionize Rectal Cancer Treatment? Abu Dhabi Clinical Trial Begins

Tue, Nov 17, 2026(5h ago)UAE

A pioneering clinical trial is currently underway at the Burjeel Cancer Institute in Abu Dhabi, testing a groundbreaking medical device that could spare rectal cancer patients from invasive, life-altering surgeries. The technology, known as the MediChip, is a biodegradable, 3D-printed implant developed by the US-based biotech firm BioSapien. By delivering chemotherapy directly to the site of a residual tumor, the device aims to shrink the cancer locally, potentially preserving the patient's rectum and sparing them from needing a permanent stoma. Dr. Khatija Ali, CEO of BioSapien, emphasizes that the primary goal of this innovation is organ preservation, offering a far less debilitating alternative to the standard, systemic chemotherapy treatments that often leave patients physically exhausted and struggling with the long-term impact of major surgery.

The current Phase I study, titled OPTIMISE-REFORM, is focused on evaluating the safety and tolerability of the implant in human patients. Unlike traditional intravenous chemotherapy, which circulates throughout the entire body and causes widespread side effects, the MediChip releases the drug 5-fluorouracil (5-FU) exclusively where it is needed most. Researchers are carefully monitoring participants to ensure the device stays in place and functions as intended, with early animal studies showing high success rates in reducing tumor size without leaking medication into the bloodstream. While the team stresses that this remains experimental, the rapid regulatory support and advanced healthcare infrastructure in Abu Dhabi have provided an ideal environment to test this technology, potentially paving the way for a more targeted, less intrusive future in cancer care.

Comments0
No comments yet. Be the first to share your thoughts.